Evidence map›Paper›PMID 25463275›Full record

ArticleJournal of molecular and cellular cardiology2015

Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.

Tatiana N Sidorova, Liudmila V Yermalitskaya, Lisa C Mace, K Sam Wells, Olivier Boutaud, Joseph K Prinsen, Sean S Davies, L Jackson Roberts, Sergey I Dikalov, Charles G Glabe and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Oxidative modification of HDL by lipid aldehydes impacts HDL function.Archives of biochemistry and biophysics · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Removing the Stress From Hypertension-Induced Atrial Fibrillation.JACC. Basic to translational science · 2020
    Article
  13. Review
  14. Cognitive dysfunction in atrial fibrillation.Nature reviews. Cardiology · 2018
    Review
  15. Isolevuglandins and cardiovascular disease.Prostaglandins & other lipid mediators · 2018
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Tatiana N SidorovaDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Liudmila V YermalitskayaDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Lisa C MaceDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
K Sam WellsDepartments of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Olivier BoutaudDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Joseph K PrinsenDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Sean S DaviesDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
L Jackson RobertsDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Sergey I DikalovDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Charles G GlabeUniversity of California, Irvine, Irvine, CA, USA.
Venkataraman AmarnathDepartments of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Joey V BarnettDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Katherine T MurrayDepartments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, USA. Electronic address: kathy.murray@vanderbilt.edu.
Vanderbilt University · USUniversity of California, Irvine · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
TISSUE REPOSITORY COREP01AG000538 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 1985 to 2018
$24.8M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIES, SEAN STEPHEN · 2014 to 2025
$24.7M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
CLINICAL PHARMACOLOGY TRAINING PROGRAMT32GM007569 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bjorn C Knollmann · 1985 to 2026
$12.4M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
Preamyloid Oligomers and Susceptibility to Atrial FibrillationR01HL096844 · NHLBI · VANDERBILT UNIVERSITY · PI MURRAY, KATHERINE T · 2010 to 2014
$1.9M
NCATS NIH HHS UL1 TR000445NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NEI NIH HHS EY08126NEI NIH HHS P30 EY008126NHLBI NIH HHS HL096844NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL096844NIA NIH HHS P01 AG000538NIDDK NIH HHS DK20593NIDDK NIH HHS DK58404NIDDK NIH HHS DK59637NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIGMS NIH HHS T32 GM007569NIH HHS S10 OD021630
6 · The paper itself

Abstract

Rapid activation causes remodeling of atrial myocytes resembling that which occurs in experimental and human atrial fibrillation (AF). Using this cellular model, we previously observed transcriptional upregulation of proteins implicated in protein misfolding and amyloidosis. For organ-specific amyloidoses such as Alzheimer's disease, preamyloid oligomers (PAOs) are now recognized to be the primary cytotoxic species. In the setting of oxidative stress, highly-reactive lipid-derived mediators known as γ-ketoaldehydes (γ-KAs) have been identified that rapidly adduct proteins and cause PAO formation for amyloid β1-42 implicated in Alzheimer's. We hypothesized that rapid activation of atrial cells triggers oxidative stress with lipid peroxidation and formation of γ-KAs, which then rapidly crosslink proteins to generate PAOs. To investigate this hypothesis, rapidly-paced and control, spontaneously-beating atrial HL-1 cells were probed with a conformation-specific antibody recognizing PAOs. Rapid stimulation of atrial cells caused the generation of cytosolic PAOs along with a myocyte stress response (e.g., transcriptional upregulation of Nppa and Hspa1a), both of which were absent in control, unpaced cells. Rapid activation also caused the formation of superoxide and γ-KA adducts in atriomyocytes, while direct exposure of cells to γ-KAs resulted in PAO production. Increased cytosolic atrial natriuretic peptide (ANP), and the generation of ANP oligomers with exposure to γ-KAs and rapid atrial HL-1 cell stimulation, strongly suggest a role for ANP in PAO formation. Salicylamine (SA) is a small molecule scavenger of γ-KAs that can protect proteins from modification by these reactive compounds. PAO formation and transcriptional remodeling were inhibited when cells were stimulated in the presence of SA, but not with the antioxidant curcumin, which is incapable of scavenging γ-KAs. These results demonstrate that γ-KAs promote protein misfolding and PAO formation as a component of the atrial cell stress response to rapid activation, and they provide a potential mechanistic link between oxidative stress and atrial cell injury.

Indexed as

Protein MultimerizationAldehydesAminesAmyloidAnimalsAtrial Natriuretic FactorCardiac Pacing, ArtificialCell LineCurcuminCytosolHeart AtriaHumansMiceModels, BiologicalOxidative StressProtein FoldingAldehydesAminesAmyloidAtrial Natriuretic FactorCurcuminSuperoxidesAmyloidosisAtrial HL-1 cellsAtrial natriuretic peptideLevuglandinOxidant stressPreamyloid oligomersγ-ketoaldehyde

Identifiers

PMID25463275
PMCPMC4302000
OpenAlexW2090138155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.